Skip to content

Aromatherapy Versus Diet

Aromatherapy Versus Diet Management on Children with Primary Nocturnal Enuresis

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06853379
Enrollment
30
Registered
2025-03-03
Start date
2025-03-05
Completion date
2025-05-10
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nocturnal Enuresis

Brief summary

Eligible children were randomly divided into 2 groups assigned to receive dietary recommendations (group A) or to receive herbal compounds (group B). Children were treated for a period of one week , then cross over the two groups is done

Interventions

. receive dietary recommendations or nonspecific dietary advices such as reducing fluid intake after 6 p.m. The list of dietary advices have been made reviewing literature and consisted in a list of recommended food, not recommended food at evening and not recommended food

the case receive aroma therapy

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
5 Years to 10 Years
Healthy volunteers
No

Inclusion criteria

* The participants age will be ranged from 5to 10 years. * primary Nocturnal enuresis(NE) number of wet nights/week is more than 4\\7

Exclusion criteria

* secondary nocturnal enuresis to any neurological disorders , musculoskeletal problems, or congenital abnormalities * the child receives any Pharmacological treatment to NE

Design outcomes

Primary

MeasureTime frameDescription
number of wet days per week; for baseline evaluation of number of wet days per week, if the number is less than 4\7 the child will be excluded from the study. Second week; group A receives dietary recommendations , group B receives herbal compoundsfor baseline evaluation of number of wet days per week, if the number is less than 4\\7 the child will be excluded from the study.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026